Skip to main content
Simris Group AB logo

Simris Group AB — Investor Relations & Filings

Ticker · SIMRIS ISIN · SE0008091664 LEI · 529900P0ACIS2UI3ZX27 ST Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST SIMRIS

About Simris Group AB

https://simris.com/

Simris Group AB is a biotechnology company focused on developing next-generation payloads for Antibody-Drug Conjugates (ADCs) to advance cancer treatment. The company leverages a proprietary technology platform built upon an extensive library of cyanobacterial strains and expertise in natural products. Through its discovery and bioconjugation technologies, Simris develops novel, IP-protected payloads designed to enhance the efficacy and safety profile of ADC therapeutics. The core activity involves identifying unique natural compounds and developing them into products for the pharmaceutical industry.

Recent filings

No filings indexed yet

We are still gathering filings for Simris Group AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.